Kangstem Biotech Co., Ltd.
- Home
- Companies
- Kangstem Biotech Co., Ltd.
- Products
- Furestem - Model AD Inj - Stem Cell ...
Furestem - Model AD Inj -Stem Cell Therapeutic Product for Atopic Dermatitis
FURESTEM-AD Inj. is the world’s first stem cell therapeutic product for atopic dermatitis that targets moderate to severe atopic dermatitis patients.
Most popular related searches
stem cell
cell therapeutic
stem cell product
stem cell therapy
dermatitis atopic
subcutaneous injection
cell therapy
subcutaneous route
- Product name : FURESTEM-AD® Inj.
- Manufacturer : Kangstem Biotech
- Target : Moderate to severe atopic dermatitis patients
- Injection route : Subcutaneous injection
MoA : IL-4 is secreted from Th2 cells. FURESTEM-AD® Inj. is stimulated by IL-4. Stimulated FURESTEM-AD® Inj. secretes TGF-ß1. TGF-ß1 suppresses expression of FceR1 receptor (during maturation of mast cells). FURESTEM-AD® Inj. secretes PGE2. PGE2 suppresses degranulation of mast cells. FURESTEM-AD® Inj. inhibits each step of mast cell activation and degranulation through the secretions of TGF-ß1 & PGE2.
